Decision letter for "Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-on to Metformin in Korean Patients with Type 2 Diabetes: A Randomized, Double-blind, Multi-center, Placebo-controlled, Phase III Trial"
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Diabetes Treatment and Management
Diabetes Management and Research
Pharmacology and Obesity Treatment
Publication details
- Journal / source
- Publons reviews and discussion
- Publication date
- 18 January 2026
- Language
- EN